Skip to main content

Table 1 (abstract P21). Changes of Leukocyte count, Platelet Indices at initial visit and at follow up

From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)

Parameters

Visits

Oligo arthritis

(n= 5)

Poly arthritis (RF Positive)

(n=2)

Poly arthritis

(RF negative)

(n=12)

SJIA

(n=15 )

ERA

(HLA positive)

(n= 16 )

TOTAL

Patients

(N= 50 )

Platelet count

(per cubic mm)

N1

274000

±45055

400000

±28284

462500

±125923

593333

±200487

454187

±146535

477740

±174957

N2

296200

±56010

400000

±70710

423333

±87835

439333

±212752

391000

±88211

404140

±138275

P-value

0.547NS

1.00 NS

0.258 NS

0.035S

0.013S

0.003S

Platelet distribution width

(PDW)

(fL)

N1

12.96

±1.99

10.70

±0.42

10.22

±1.32

9.27

±0.77

12.46

±7.16

10.95

±4.33

N2

15.20

±8.01

11.05

±1.62

18.29

±12.90

11.24

±2.18

16.49

±11.23

15

±9.54

P-value

0.572NS

0.751 NS

0.049 S

0.004S

0.278 NS

0.009S

Total count of Leukocyte

(per cubic mm)

N1

8900

±1024

10500

±2121

11791

±2719

16760

±7099

10850

±2049

12640

±5055

N2

8910

±1582

12650

±1626

10566

±3466

12280

±4334

9118

±2431

10535

±3489

P-value

0.99NS

0.103NS

0.166 NS

0.017 S

0.003 S

0.001S

  1. Data were presented as mean ±SD
  2. P value reached from unpaired t-test and p values < 0.05 accepted as statistically significant
  3. SD = Standard Deviation
  4. n = Number of patients in each JIA types
  5. N = Total number of patients
  6. N1= Initial visit
  7. N2= 06 months
  8. S = Statistically Significant
  9. NS = Not Significant